Nonproliferative Diabetic Retinopathy: What You Need to Know
Schedule Today
Who Is at Risk and Why
Diabetic retinopathy is one of the most common complications of diabetes and affects millions of adults across the country. Several factors influence who develops NPDR and how quickly it progresses.
Diabetic retinopathy affects roughly one in four people living with diabetes in the United States. It affects more Americans than age-related macular degeneration and glaucoma combined. Both type 1 and type 2 diabetes can lead to retinal damage, and the risk increases the longer a person has had diabetes.
The duration of diabetes is one of the strongest predictors of developing NPDR. Research has shown that NPDR was present in approximately one quarter of patients five years after a diabetes diagnosis, rising to about 60 percent at ten years and 80 percent at fifteen years. Consistently elevated blood glucose accelerates damage to retinal blood vessels, so maintaining blood sugar levels as close to your target range as possible is one of the most effective ways to slow or prevent NPDR progression.
Beyond blood sugar, several other factors influence the risk and severity of NPDR. High blood pressure, also called hypertension, places additional stress on already weakened retinal vessels. Elevated triglyceride levels, excess body weight, and smoking are also linked to greater risk and faster progression.
People who have diabetic peripheral neuropathy, a form of nerve damage that affects the hands and feet, often share the same underlying risk factors as those with advanced retinal disease. A specialist will consider your full health picture when assessing your level of risk.
Signs and Symptoms of NPDR
One of the most challenging aspects of NPDR is that it often produces no warning signs until it has already advanced. Knowing what to watch for, and when to act quickly, can protect your vision.
In its early and moderate stages, NPDR frequently causes no noticeable symptoms. Many people see clearly and feel no eye discomfort even while retinal damage is occurring. The changes happen at a microscopic level inside the retina, where they cannot be felt or seen without specialized equipment.
This is precisely why annual dilated eye exams are so important for anyone living with diabetes. By the time vision changes become noticeable, the disease may have already progressed significantly.
When NPDR does affect vision, it is usually because of diabetic macular edema, or DME. DME occurs when fluid leaks into the macula, the central portion of the retina responsible for sharp, detailed vision used for reading, driving, and recognizing faces. This can cause blurred or distorted central vision that develops gradually rather than suddenly.
Some patients also notice that colors appear faded or washed out. Macular ischemia, a reduction in blood flow to the macula, can also reduce vision clarity and is more difficult to treat.
Certain symptoms can signal that diabetic retinopathy has progressed to a more serious stage. If you experience any of the following, contact a specialist right away or go to the nearest emergency room.
- A sudden increase in floaters, which are spots or strings that drift across your vision
- Flashes of light in one or both eyes
- A shadow or dark curtain appearing across part of your visual field
- Sudden loss of vision in one eye
Treatment Options for NPDR
Treatment for NPDR depends on the stage of the condition and whether macular edema is present. Options range from careful observation and lifestyle management to injection therapy and, in certain cases, laser treatment.
For many patients with mild to moderate NPDR who do not have macular edema, the primary approach is careful monitoring combined with strong control of overall health. This is supported by long-term research from the Early Treatment Diabetic Retinopathy Study. The goal is to prevent progression by addressing the underlying conditions that drive retinal damage.
- Keeping blood sugar and hemoglobin A1c levels as close to your target as your care team recommends
- Managing blood pressure to reduce stress on retinal blood vessels
- Controlling cholesterol and triglyceride levels
- Quitting smoking
- Maintaining a healthy body weight
Anti-VEGF medications work by blocking a protein called vascular endothelial growth factor, which drives abnormal blood vessel growth and leakage in the retina. Several anti-VEGF agents, including aflibercept and ranibizumab, have been approved for the treatment of diabetic retinopathy. Bevacizumab is also widely used in retinal care. Faricimab, a newer bispecific antibody that targets both VEGF and another protein called Ang-2, is approved for diabetic macular edema.
These medications are delivered as intravitreal injections, meaning they are administered directly into the eye by a specialist. While this sounds intimidating, the procedure is performed with numbing drops and is generally well tolerated.
Clinical trials including PANORAMA and Protocol W have examined the benefit of early anti-VEGF treatment in eyes with moderately severe to severe NPDR. These studies showed that early treatment can improve disease severity scores and reduce the risk of vision-threatening complications. However, four-year data from Protocol W also showed that early treatment for NPDR without center-involved macular edema did not produce a long-term visual acuity benefit compared to observation alone.
This means that for many patients with NPDR who do not yet have macular edema, careful monitoring may still be preferred over immediate treatment. A specialist will weigh the severity of NPDR, the presence or absence of macular edema, and your overall health when recommending a plan.
Scatter laser photocoagulation, also known as panretinal photocoagulation or PRP, uses thermal laser energy to treat areas of the retina with poor blood flow. While this approach is more commonly associated with advanced PDR, selected cases of severe NPDR may also benefit. Laser treatment does not improve vision but is intended to reduce the risk of progression to more serious disease. This approach is supported by findings from long-term clinical research.
Fenofibrate is a medication primarily used to lower triglycerides. Research from the FIELD study suggested that fenofibrate may also help slow the progression of diabetic retinopathy, with the most noticeable protective effect seen in patients with mild NPDR. Whether this medication is appropriate for you is a conversation to have with both your eye specialist and your primary care physician or endocrinologist.
Monitoring and Follow-Up
Because NPDR can change over time, consistent monitoring is essential to catching any progression early and adjusting your care plan when needed. The frequency of your visits will depend on the stage of your condition.
If you are diagnosed with mild NPDR, a specialist will typically recommend follow-up exams every six to twelve months. Moderate NPDR usually requires visits every three to six months. Severe NPDR may call for follow-up every two to four months because of the elevated risk of progression to PDR. Your monitoring schedule may be adjusted based on how your condition responds to management and what new findings appear on imaging.
At each visit, a specialist will perform a dilated exam and often obtain OCT imaging to assess the macula. You may be asked about recent changes in your vision, your latest blood sugar readings, and any updates to your medications. These visits are designed to detect early signs of worsening so that treatment can be started promptly if needed.
If macular edema develops or NPDR worsens significantly, a specialist may recommend starting intravitreal injection therapy. Initial treatment typically involves injections given every four to eight weeks, with the interval between treatments often extended over time based on how the eye responds. The goal is to protect vision and prevent further damage to the retina.
Living Well With NPDR
A diagnosis of NPDR calls for active partnership between you, your eye care team, and your primary care providers. Daily choices have a real impact on the health of your retina over time.
The most impactful steps you can take are controlling your blood sugar, blood pressure, and cholesterol. These three factors are the primary drivers of retinal blood vessel damage. Working closely with your primary care physician or endocrinologist to set and meet appropriate targets is essential to slowing or preventing NPDR progression.
Regular physical activity, a balanced diet, maintaining a healthy weight, and avoiding smoking all contribute to better outcomes for people with NPDR. These habits support blood vessel health throughout the entire body, including the retina. Even modest, consistent improvements in these areas can make a meaningful difference over time.
Learning that you have a condition that can affect your eyesight can be stressful and worrying. It helps to know that mild to moderate NPDR often remains stable for years with proper management, and that many people with NPDR maintain good vision throughout their lives. Staying informed, attending all scheduled appointments, and following your treatment plan are the most effective tools you have. If you notice any vision changes between appointments, contact a specialist promptly rather than waiting for your next scheduled visit.
Frequently Asked Questions
These answers are intended to address common concerns and help guide practical decisions about NPDR care.
Yes, in some cases. Clinical trials have shown that anti-VEGF therapy can improve scores on the retinal severity scale, meaning the visible signs of NPDR can be reduced. This is not the same as a complete reversal of all underlying damage to the retinal tissue. Whether treatment is appropriate for your specific situation depends on the severity of NPDR, whether macular edema is present, and your overall health, all of which a specialist will evaluate with you.
Not necessarily. Many patients with mild to moderate NPDR and no macular edema are managed with observation and systemic health control rather than immediate injection therapy. Long-term research has shown that early anti-VEGF treatment for NPDR without macular edema involving the center of the macula does not reliably provide a long-term visual acuity benefit compared to careful monitoring. The decision to treat is always individualized and based on your full clinical picture.
Progression varies from person to person and depends on several factors including diabetes duration, blood sugar control, blood pressure, and the current severity of NPDR. Patients with mild NPDR who maintain good systemic control may remain stable for many years. Those with severe NPDR carry a substantially higher risk of advancing to proliferative disease within one year. This is why the stage of NPDR is so important in determining how frequently you need to be monitored.
A diagnosis of NPDR does not mean vision loss is inevitable. Many people with mild to moderate NPDR maintain good vision for years or even decades with appropriate management. The greatest risk of serious vision loss comes from untreated macular edema or progression to advanced proliferative diabetic retinopathy, both of which can be addressed when caught early. Regular monitoring and proactive control of diabetes and related conditions significantly reduce that risk.
There is currently no strong clinical evidence that any over-the-counter supplement can prevent or meaningfully treat diabetic retinopathy. Some research has explored antioxidants and omega-3 fatty acids, but results have not been consistent enough to support a firm recommendation. The approaches with the strongest evidence remain blood sugar control, blood pressure management, lipid management, and regular monitoring by a qualified specialist.
If you experience sudden vision loss in one eye, a shadow or dark curtain covering part of your vision, or a dramatic sudden increase in floaters accompanied by flashes of light, go to an emergency room immediately rather than waiting for a routine appointment. These symptoms can signal a retinal tear or detachment, which requires urgent evaluation. For gradual changes such as mild blurring or slightly altered color perception, contact a specialist promptly to schedule an evaluation within a few days.
Schedule Your Diabetic Eye Exam
Our team is committed to providing thorough, compassionate diabetic eye care for patients throughout our community. Early detection of NPDR gives you the best possible chance of preserving clear, healthy vision for years to come. We use advanced retinal imaging and the most current evidence-based approaches to help guide your care every step of the way. Contact our office to schedule a comprehensive dilated eye exam and take an active role in protecting your sight.